Nicholas E. Powers
Impact in
-
- Immune cells in cancer
- Immune Cell Function and Interaction
- Immunotherapy and Immune Responses
- IL-33, ST2, and ILC Pathways
- Immune Response and Inflammation
-
- Cancer Immunotherapy and Biomarkers
Papers in
-
- Immune Response and Inflammation 3
- Immune cells in cancer 3
- IL-33, ST2, and ILC Pathways 2
-
- Gout, Hyperuricemia, Uric Acid 2
- Co-authors
- Charles Anthony Dinarello (7 shared papers)Leo A. B. Joosten (3 shared papers)Carlo Marchetti (3 shared papers)Isak W. Tengesdal (3 shared papers)Alberto Dinarello (2 shared papers)Matthew A. Burchill (1 shared paper)A V Edwards (1 shared paper)Dennis M. de Graaf (4 shared papers)
- Journals
- Journal of Biological Chemistry (3 papers)Nature (1 paper)Cytokine (1 paper)PLoS Pathogens (1 paper)Pharmaceuticals (1 paper)
- Partner nations
- United StatesNetherlandsGermany
In The Last Decade
Nicholas E. Powers
10 papers receiving 247 citations
Peers
Comparison fields: 5 of 59
- Immunology 120
- Oncology 53
- Molecular Biology 118
- Hematology 18
- Dermatology 10
Countries citing papers authored by Nicholas E. Powers
This map shows the geographic impact of Nicholas E. Powers's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nicholas E. Powers with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nicholas E. Powers more than expected).
Fields of papers citing papers by Nicholas E. Powers
This network shows the impact of papers produced by Nicholas E. Powers. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nicholas E. Powers. The network helps show where Nicholas E. Powers may publish in the future.
Co-authors
The 25 scholars most cited alongside Nicholas E. Powers, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 83 | |
| 2 | 2022 | 27 | |
| 3 | 2020 | 25 | |
| 4 | 2020 | 23 | |
| 5 | 2022 | 23 | |
| 6 | 2020 | 18 | |
| 7 | 2021 | 17 | |
| 8 | 2019 | 15 | |
| 9 | 1967 | 15 | |
| 10 | 2023 | 7 |
About Nicholas E. Powers
Nicholas E. Powers is a scholar working on Immunology, Nephrology, Oncology, Molecular Biology and Rehabilitation, having authored 10 papers that have together received 253 indexed citations. Recurring topics across this work include Inflammasome and immune disorders (6 papers), Immune Response and Inflammation (3 papers), Immune cells in cancer (3 papers), Gout, Hyperuricemia, Uric Acid (2 papers), IL-33, ST2, and ILC Pathways (2 papers), Cancer Immunotherapy and Biomarkers (2 papers), Cytokine Signaling Pathways and Interactions (2 papers) and Autophagy in Disease and Therapy (1 paper). The work is most often cited by research in Immunology (120 citations), Oncology (53 citations), Molecular Biology (118 citations), Hematology (18 citations) and Dermatology (10 citations). Nicholas E. Powers has collaborated with scholars based in United States, Netherlands and Germany. Frequent co-authors include Charles Anthony Dinarello, Leo A. B. Joosten, Carlo Marchetti, Isak W. Tengesdal, Alberto Dinarello, Matthew A. Burchill, A V Edwards, Dennis M. de Graaf, Suzhao Li and Arne Skerra. Their work appears in journals such as Journal of Biological Chemistry, Nature, Cytokine, PLoS Pathogens and Pharmaceuticals.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.